Data regarding outcomes after percutaneous transcatheter tricuspid-valve replacement ... 5.3% of the control group (P=0.003); new permanent pacemakers were implanted in 17.4% and 2.3% ...

The trial was small and halted early, but investigators say the inflammatory hypothesis in TAVI is worth pursuing further.

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

Compared with SAVR, TAVR was associated with an increased likelihood of needing a pacemaker and moderate-to-severe paravalvular leaks. Notably, on a prespecified analysis, the study addressed the ...

TTVR also led to "near elimination" of the TR, as 99.1% of people had moderate or less TR (and 95.3% mild or less) at the ...

The RHEIA trial studied women with severe aortic stenosis and found that participants preferred transcatheter aortic valve replacement over surgical valve replacement.

The child who underwent device closure along with pacemaker implantation developed pacing lead ... our study with a large number of patients shows the safety of transcatheter device closure in this ...

Transcatheter tricuspid-valve replacement is superior to medical therapy alone for patients with severe tricuspid ...

A new study published in the New England Journal of Medicine showed that improvements in symptoms and quality of life were ...